BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 21821550)

  • 1. Histology and outcomes of newly detected lung lesions in melanoma patients.
    Smyth EC; Hsu M; Panageas KS; Chapman PB
    Ann Oncol; 2012 Mar; 23(3):577-582. PubMed ID: 21821550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy.
    Horn J; Lock-Andersen J; Sjøstrand H; Loft A
    Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):887-92. PubMed ID: 16586078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of non-aggressive stage IA lung cancer using chest computed tomography and positron emission tomography/computed tomography.
    Shiono S; Yanagawa N; Abiko M; Sato T
    Interact Cardiovasc Thorac Surg; 2014 Oct; 19(4):637-43. PubMed ID: 24994703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse interstitial infiltrative lung metastasis of malignant melanoma: a case report.
    Shin NY; Hong YJ; Kim AH; Shim HS; Nam JE; Lee HJ; Kim MJ
    Korean J Radiol; 2011; 12(2):252-5. PubMed ID: 21430944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2-fluoro-2-deoxy-D-glucose avidity on positron emission tomography/computed tomography.
    Bar-Shalom R; Kagna O; Israel O; Guralnik L
    Cancer; 2008 Dec; 113(11):3213-21. PubMed ID: 18924145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis.
    Dewan NA; Reeb SD; Gupta NC; Gobar LS; Scott WJ
    Chest; 1995 Aug; 108(2):441-6. PubMed ID: 7634881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose.
    Böni R; Böni RA; Steinert H; Burg G; Buck A; Marincek B; Berthold T; Dummer R; Voellmy D; Ballmer B
    Br J Dermatol; 1995 Apr; 132(4):556-62. PubMed ID: 7748746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of radiologic imaging at the time of initial diagnosis of stage T1b-T3b melanoma.
    Yancovitz M; Finelt N; Warycha MA; Christos PJ; Mazumdar M; Shapiro RL; Pavlick AC; Osman I; Polsky D; Berman RS
    Cancer; 2007 Sep; 110(5):1107-14. PubMed ID: 17620286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of non-calcified pulmonary nodules in patients with extrapulmonary cancers.
    Khokhar S; Vickers A; Moore MS; Mironov S; Stover DE; Feinstein MB
    Thorax; 2006 Apr; 61(4):331-6. PubMed ID: 16467070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple positron-emission tomography false positives in a patient with malignant melanoma.
    Cho D; Kocher O; Parker JA; Halmos B
    Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):87-8. PubMed ID: 16477930
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of computed tomography scan abnormalities in patients with biopsy-proven hepatic metastases from uveal melanoma.
    Patel M; Winston CB; Marr BP; Carvajal RD; Schwartz GK; Wolchok J; Busam K; Abramson DH
    Arch Ophthalmol; 2011 Dec; 129(12):1576-82. PubMed ID: 22159677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node staging of cutaneous melanoma: predictors and outcomes.
    Ellis MC; Weerasinghe R; Corless CL; Vetto JT
    Am J Surg; 2010 May; 199(5):663-8. PubMed ID: 20466113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indeterminate pulmonary nodules in colorectal cancer.
    Jung EJ; Kim SR; Ryu CG; Paik JH; Yi JG; Hwang DY
    World J Gastroenterol; 2015 Mar; 21(10):2967-72. PubMed ID: 25780294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.
    Bryant A; Cerfolio RJ
    Chest; 2007 Jul; 132(1):185-92. PubMed ID: 17573517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
    Kurli M; Reddy S; Tena LB; Pavlick AC; Finger PT
    Am J Ophthalmol; 2005 Aug; 140(2):193-9. PubMed ID: 15992753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response.
    Samstein RM; Carvajal RD; Postow MA; Callahan MK; Shoushtari AN; Patel SG; Lee NY; Barker CA
    Head Neck; 2016 Sep; 38(9):1310-7. PubMed ID: 27043023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
    Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
    Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
    Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
    Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose.
    Steinert HC; Huch Böni RA; Buck A; Böni R; Berthold T; Marincek B; Burg G; von Schulthess GK
    Radiology; 1995 Jun; 195(3):705-9. PubMed ID: 7753998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging-guided biopsy of (18)F-FDG-avid extrapulmonary lesions: do lesion location and morphologic features on CT affect the positive predictive value for malignancy?
    Nguyen ML; Gervais DA; Blake MA; Mueller PR; Sahani DV; Hahn PF; Uppot RN
    AJR Am J Roentgenol; 2013 Aug; 201(2):433-8. PubMed ID: 23883226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.